Literature DB >> 17942779

Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload.

Debasish Banerjee1, Jennie Z Ma, Allan J Collins, Charles A Herzog.   

Abstract

BACKGROUND AND OBJECTIVES: Mortality in patients who are on maintenance hemodialysis and have congestive heart failure is high in small cohort studies. The aim of this study was to determine long-term survival in a large cohort of dialysis patients with congestive heart failure and suspected fluid overload or pulmonary edema. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data were analyzed, retrospectively, on 1,119,808 patients who started hemodialysis between January 1977 and December 1999. Survival was estimated from the first (index) hospital admission with congestive heart failure, fluid overload, or pulmonary edema, after 60 d of successful hemodialysis using the life-table method. The impact of patient characteristics on outcome was assessed by the Cox proportional hazards model.
RESULTS: Of the 310,456 patients included in the study, 233,454 were admitted with congestive heart failure, 63,886 with fluid overload, and 13,116 with pulmonary edema. The patients with congestive heart failure were older and often white and had diabetes or hypertension as the cause of renal failure. Deaths during the index hospital admission were 8.7% for congestive heart failure, 4.0% for fluid overload, and 6.6% for pulmonary edema. Five-year survival was 12.5, 20.2, and 21.3%, respectively. The independent positive predictors for mortality in these patients were age, male gender, diabetes, hypertension, history of cardiovascular disease, and congestive heart failure.
CONCLUSIONS: This study demonstrates very poor survival in dialysis patients who present with congestive heart failure, pulmonary edema, or fluid overload compared with patients who present with congestive heart failure without renal failure. Meticulous management of cardiovascular risk should improve survival.

Entities:  

Mesh:

Year:  2007        PMID: 17942779     DOI: 10.2215/CJN.01110307

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  14 in total

1.  Physical function at the time of dialysis initiation is associated with subsequent mortality.

Authors:  Daijo Inaguma; Akihito Tanaka; Hibiki Shinjo
Journal:  Clin Exp Nephrol       Date:  2016-07-08       Impact factor: 2.801

Review 2.  Decision-making under uncertainty in advanced heart failure.

Authors:  Theo E Meyer; Michael S Kiernan; David D McManus; Jeffrey Shih
Journal:  Curr Heart Fail Rep       Date:  2014-06

3.  In-hospital mortality in patients with renal dysfunction admitted for myocardial infarction: the Emilia-Romagna region of Italy database of hospital admissions.

Authors:  Fabio Fabbian; Marco Pala; Alfredo De Giorgi; Fabio Manfredini; Alessandra Mallozzi Menegatti; Raffaella Salmi; Francesco Portaluppi; Massimo Gallerani; Roberto Manfredini
Journal:  Int Urol Nephrol       Date:  2012-07-25       Impact factor: 2.370

4.  Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study.

Authors:  Nisha Bansal; Jason Roy; Hsiang-Yu Chen; Rajat Deo; Mirela Dobre; Michael J Fischer; Elyse Foster; Alan S Go; Jiang He; Martin G Keane; John W Kusek; Emile Mohler; Sankar D Navaneethan; Mahboob Rahman; Chi-Yuan Hsu
Journal:  Am J Kidney Dis       Date:  2018-05-18       Impact factor: 8.860

5.  Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Deborah L Regidor; Csaba P Kovesdy; David Van Wyck; Suphamai Bunnapradist; Tamara B Horwich; Gregg C Fonarow
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

6.  The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study.

Authors:  Claudia Torino; Luna Gargani; Rosa Sicari; Krzysztof Letachowicz; Robert Ekart; Danilo Fliser; Adrian Covic; Kostas Siamopoulos; Aristeidis Stavroulopoulos; Ziad A Massy; Enrico Fiaccadori; Alberto Caiazza; Thomas Bachelet; Itzchak Slotki; Alberto Martinez-Castelao; Marie-Jeanne Coudert-Krier; Patrick Rossignol; Faikah Gueler; Thierry Hannedouche; Vincenzo Panichi; Andrzej Wiecek; Giuseppe Pontoriero; Pantelis Sarafidis; Marian Klinger; Radovan Hojs; Sarah Seiler-Mussler; Fabio Lizzi; Dimitrie Siriopol; Olga Balafa; Linda Shavit; Rocco Tripepi; Francesca Mallamaci; Giovanni Tripepi; Eugenio Picano; Gérard Michel London; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-22       Impact factor: 8.237

7.  Considerations in the statistical analysis of hemodialysis patient survival.

Authors:  Christos Argyropoulos; Chung-Chou H Chang; Laura Plantinga; Nancy Fink; Neil Powe; Mark Unruh
Journal:  J Am Soc Nephrol       Date:  2009-07-30       Impact factor: 10.121

8.  Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort).

Authors:  Nisha Bansal; Charles E McCulloch; Feng Lin; Arnold Alper; Amanda H Anderson; Magda Cuevas; Alan S Go; Radhakrishna Kallem; John W Kusek; Claudia M Lora; Eva Lustigova; Akinlolu Ojo; Mahboob Rahman; Cassianne Robinson-Cohen; Raymond R Townsend; Jackson Wright; Dawei Xie; Chi-Yuan Hsu
Journal:  Hypertension       Date:  2017-07-03       Impact factor: 10.190

9.  Mid-term results of surgical aortic valve replacement with bioprostheses in hemodialysis patients.

Authors:  Ikuko Shibasaki; Taira Fukuda; Hironaga Ogawa; Go Tsuchiya; Yusuke Takei; Masahiro Seki; Takashi Kato; Yuta Kanazawa; Shunsuke Saito; Toshiyuki Kuwata; Yasuyuki Yamada; Yasuo Haruyama; Hirotsugu Fukuda
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-11

10.  Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study.

Authors:  Magdalene M Assimon; Thuy Nguyen; Suzanne L Katsanos; Steven M Brunelli; Jennifer E Flythe
Journal:  BMC Nephrol       Date:  2016-11-11       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.